Detalhe da pesquisa
1.
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year results from DASCERN.
Haematologica
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695123
2.
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.
Ann Hematol
; 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38888616
3.
TES and SLC40A1 as potential biomarkers for predicting survival in T-cell acute lymphoblastic leukemia.
Acta Haematol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38806013
4.
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-ß-SMAD2/3 pathway.
Mol Med
; 29(1): 59, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098464
5.
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.
BMC Cancer
; 23(1): 980, 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37838670
6.
Efficacy and safety of the C5 inhibitor crovalimab in complement inhibitor-naive patients with PNH (COMMODORE 3): A multicenter, Phase 3, single-arm study.
Am J Hematol
; 98(9): 1407-1414, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421604
7.
Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.
BMC Med
; 20(1): 108, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379237
8.
Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/ß-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
Br J Haematol
; 193(5): 928-940, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959953
9.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Am J Hematol
; 98(7): E183-E186, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128776
10.
Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Mol Cancer
; 14: 26, 2015 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25644173
11.
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia.
Cancer Cell Int
; 15: 93, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26448723
12.
Role of Toll-like receptor 4 signaling in cutaneous chronic graft-versus-host disease.
Clin Transplant
; 29(6): 547-54, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845646
13.
WT1 mRNA level reflects disease changes and progression of myelodysplastic syndromes patients with 'stable disease'.
Br J Haematol
; 184(3): 447-450, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359800
14.
Outcomes of intermediate or high-risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience.
Clin Transl Sci
; 17(1): e13711, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129985
15.
The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation.
Mol Cancer
; 12: 73, 2013 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23849082
16.
Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.
Mol Ther
; 20(12): 2347-54, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23070118
17.
Bortezomib modulates regulatory T cell subpopulations in the process of acute graft-versus-host disease.
Clin Lab
; 59(1-2): 51-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505906
18.
Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.
Clin Transl Oncol
; 25(6): 1805-1820, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36899123
19.
Stem cell-based therapy for COVID-19.
Int Immunopharmacol
; 124(Pt A): 110890, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688914
20.
Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
Int Immunopharmacol
; 117: 109746, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827923